BioSpace News Archive

Today, the Lupus Foundation of America recognizes two leading scientists for their remarkable contributions to lupus research at the 2018 Evelyn V. Hess Reception to be held this evening in Chicago, Ill. during the 2018 American College of Rheumatology (ACR) Annual Scientific Meeting.

Integrated safety analysis reflects long-term results from 3,492 treated patients for 7,860 patient-years of exposure

Gcobisa Madlolo, an activist, a writer, a proud mother of twins and a fresh, inspiring and powerful voice for young women in her native South Africa and beyond is the recipient of the fifth Omololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy.

Live conference call and webcast on Monday, October 22 at 8:00 AM ET

Patients in a real-world setting experienced similar dosing patterns as seen in the pivotal Phase 3 NAPOLI-1 clinical trial

In two first of their kind research studies, the Lupus Foundation of America (LFA) has identified needs in lupus provider education and care practices for minority patients.

Teva Pharmaceuticals announced that Teva executives Kåre Schultz and Brendan O’Grady, alongside State of New Jersey Governor, Phil Murphy, formalized Teva’s commitment to consolidate its North America Commercial business areas into New Jersey (NJ) today at the company’s global headquarters in Petach Tikva, Israel.

BioArctic AB announced today that the European Patent Office (EPO) has issued a decision to grant the company’s patent application in Europe, EP09738534.8, for its Parkinson’s disease concept patent. The decision states that the European patent, EP 2 282 758 B1, will enter into force on November 21, 2018.

Autoimmune Profile Test (AIP) shows promise for stratifying patients based on Type I interferon expression levels

Varian today announced the Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy treatments.